Evidence map›Paper›PMID 36239615›Full record

ArticleHuman vaccines & immunotherapeutics2022

Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable

Amit Bhavsar, Janusz Zaryczański, Anna Wasilewska, Delphine Saragoussi, Raghavendra Devadiga, Chris Colby, Enas Bahar, Jacek Wysocki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 5 countries.

Amit BhavsarGSK, Wavre, Belgium.ORCID 0000-0002-5956-2003
Janusz ZaryczańskiUniversity of Opole, Opole, Poland.ORCID 0000-0002-1782-6701
Anna WasilewskaMedical University of Bialystok, Bialystok, Poland.ORCID 0000-0003-0257-4422
Delphine SaragoussiEvidera, London, UK.ORCID 0000-0003-3631-3490
Raghavendra DevadigaGSK, Bangalore, India.ORCID 0000-0002-3224-6043
Chris ColbyEvidera, San Francisco, California, USA.ORCID 0000-0002-1013-880X
Enas BaharModis, C/O GSK, Wavre, Belgium.ORCID 0000-0003-4827-8311
Jacek WysockiPoznan University of Medical Sciences, Poznan, Poland.ORCID 0000-0002-5360-5826
EVRAZ (United Kingdom) · GBGlaxoSmithKline (Belgium) · BEGlaxoSmithKline (India) · INIthaka Harbors · USMedical University of Białystok · PLPoznan University of Medical Sciences · PLUniversity of Opole · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As infection with

Indexed as

Pneumococcal InfectionsPneumonia, BacterialPneumonia, PneumococcalPneumonia, ViralChildHaemophilus influenzaeHumansInfantMass VaccinationPneumococcal VaccinesStreptococcus pneumoniaeVaccinationVaccines, ConjugatePneumococcal VaccinesVaccines, Conjugatechest radiographICD-10incidencePHiD-CVpneumococcal conjugate vaccinePneumoniaPolanduniversal mass vaccination

Identifiers

PMID36239615
PMCPMC9746359
OpenAlexW4306176880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.